NCT04390984 2021-01-11
Drug-drug Interaction Study of Gefitinb on Apatinib in NSCLC Patients
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Unknown
Clinical Trials
5 trialsNCT02151721 2018-02-05
VICTORY-J
Kanazawa University
Phase 1 Unknown
NCT03050411 2017-02-10
Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer
Peking University Third Hospital
Phase 1 Unknown
NCT02321293 2015-09-02
CURCUMIN
Lady Davis Institute
Phase 1 Unknown
NCT00497250 2008-10-21
Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy
Fudan University
Phase 1 Unknown